Literature DB >> 19286500

Serum acute phase protein concentrations in female dogs with mammary tumors.

Fernando Tecles1, Marco Caldín, Anna Zanella, Francisco Membiela, Asta Tvarijonaviciute, Silvia Martínez Subiela, José Joaquín Cerón.   

Abstract

Acute phase proteins (APPs) are proteins whose concentrations in serum change after any inflammatory stimulus or tissue damage. The aim of the current study was to evaluate 3 positive APPs (C-reactive protein, serum amyloid A, and haptoglobin) and 1 negative APP (albumin) in female dogs with mammary neoplasia. Acute phase proteins were studied in 70 female dogs aged 8-12 years in the following groups: healthy (n = 10); mammary tumors in stages I (n = 19), II (n = 5), III (n = 6), IV (n = 5), and V (n = 7); and with mammary neoplasia plus a concomitant disease (n = 18). In animals with mammary neoplasia, significant increases of positive APPs were only detected in those that had metastasis or a neoplasm with a diameter greater than 5 cm and ulceration. Dogs with mammary neoplasia and a concomitant disease also had high C-reactive protein concentrations. Albumin concentration was decreased in animals with metastasis and with a concomitant disease. The results of the present study indicate that the acute phase response could be stimulated in female dogs with mammary gland tumors because of different factors, such as metastasis, large size of the primary mass, and ulceration or secondary inflammation of the neoplasm.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19286500     DOI: 10.1177/104063870902100206

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  9 in total

Review 1.  Acute phase response in animals: a review.

Authors:  Carolyn Cray; Julia Zaias; Norman H Altman
Journal:  Comp Med       Date:  2009-12       Impact factor: 0.982

2.  Investigation of serum concentrations and immunohistochemical localization of α1-acid glycoprotein in tumor dogs.

Authors:  Masashi Yuki; Noboru Machida; Takayuki Sawano; Hiroshi Itoh
Journal:  Vet Res Commun       Date:  2010-10-21       Impact factor: 2.459

3.  Plasma free amino acid profiles of canine mammary gland tumors.

Authors:  Kazuo Azuma; Tomohiro Osaki; Takeshi Tsuka; Tomohiro Imagawa; Saburo Minami; Yoshiharu Okamoto
Journal:  J Vet Sci       Date:  2012-12       Impact factor: 1.672

4.  Development and validation of a multivariable model and online decision-support calculator to aid in preoperative discrimination of benign from malignant splenic masses in dogs.

Authors:  Kristine E Burgess; Lori Lyn Price; Ryan King; Manlik Kwong; Eliza Grant; Katherine A Olson; Jeremiah A Lyons; Nicholas A Robinson; Kristin M Wendelburg; John Berg
Journal:  J Am Vet Med Assoc       Date:  2021-06-15       Impact factor: 1.936

5.  Comparison of the acute phase protein and antioxidant responses in dogs vaccinated against canine monocytic ehrlichiosis and naive-challenged dogs.

Authors:  Nir Rudoler; Shimon Harrus; Silvia Martinez-Subiela; Asta Tvarijonaviciute; Michael van Straten; Jose J Cerón; Gad Baneth
Journal:  Parasit Vectors       Date:  2015-03-23       Impact factor: 3.876

6.  Extremely high canine C-reactive protein concentrations > 100 mg/l - prevalence, etiology and prognostic significance.

Authors:  Sarah Hindenberg; Natali Bauer; Andreas Moritz
Journal:  BMC Vet Res       Date:  2020-05-20       Impact factor: 2.741

Review 7.  Acute phase proteins in animals.

Authors:  Carolyn Cray
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 8.  Serum Amyloid A as a Promising Biomarker in Domestic Animals' Reproduction: Current Knowledge and Future Perspective.

Authors:  Marilena Bazzano; Andrea Marchegiani; Alessandro Troisi; Amy McLean; Fulvio Laus
Journal:  Animals (Basel)       Date:  2022-02-25       Impact factor: 2.752

9.  Serum amyloid A promotes invasion of feline mammary carcinoma cells.

Authors:  Takashi Tamamoto; Koichi Ohno; Yuko Goto-Koshino; Hajime Tsujimoto
Journal:  J Vet Med Sci       Date:  2014-05-15       Impact factor: 1.267

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.